Table 2: Clinical presentation of patients with posttransplant MN.

VariablesN = 41

Proteinuria > 0.3 g/g or g/24h, n(%)31 (75.6)
Proteinuria1 (g/g or g/24h), mean ± DP3.2 ± 1.2
Time to onset of proteinuria > 0.3 g/g or g/24h (months), mean ± DP49.5 ± 49.7 (median = 40)
Serum albumin1 (g/dL), mean ± DP3.4 ± 0.6
Serum total cholesterol1 (mg/dL), mean ± DP198.8 ± 58.6
Serum triglycerides1 (mg/dL), mean ± DP178.5 ± 78.7
Systolic blood pressure1 (mmHg), mean ± DP131 ± 7.8
Diastolic blood pressure1 (mmHg), mean ± DP82.2 ± 6.5
Graft dysfunction1, n(%)14 (34.1)
Serum creatinine1 (mg/dL), mean ± DP1.7 ± 0.6
eGFR1 (mL/min/1.73m2), mean ± DP41.9 ± 14.3
eGFR decrease1 (%), mean ± DP26.8 ± 16.4
Time between proteinuria and graft biopsy (months), mean ± DP3.7 ± 2.5
Time between KT and graft biopsy (months), mean ± DP53.4 ± 51.5 (median = 41)
Histological stages of MN, n(%)
 Stage 110 (24.4)
 Stage 225 (60.9)
 Stage 36 (14.7)

eGFR: estimated glomerular filtration rate; KT: kidney transplant.
1 At diagnosis.